The novel morphinans 13 ± 18, which carry amino acid substituents at C(6), with potentially limited access to the central nervous system were prepared in two steps from 14-O-methyloxymorphone (5). Reductive amination with amino acid tert-butyl esters gave compounds 7 ± 12, which were hydrolyzed with tetrafluoroboric acid. Structure elucidation (including X-ray analysis), preliminary m-opioid receptor binding studies, and calculations of pharmacokinetic parameters were carried out.